Novo Nordisk's pricing techniques during the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, who may have accused the company of rate gouging, mentioning the stark distinction among U.S. rates and people in Europe and copyright.In Oct 2024, Novo Nordisk printed a analyze on scientific journal Mother nature about a novel glucose